THE IMPACT OF METABOLIC SYNDROME ON THE PROGNOSIS AND COURSE OF ENDOMETRIAL CANCER: CLINICAL, BIOCHEMICAL ASPECTS AND THERAPEUTIC APPROACHES

Akbarova, Maftuna

Жанубий оролбўйи тиббиёт журнали · 2026-yil

Annotatsiya

Endometrial cancer is one of the most common gynecological malignancies worldwide, with its incidence closely associated with metabolic disorders. Metabolic syndrome, characterized by obesity, insulin resistance, dyslipidemia, and hypertension, has been identified as a significant risk factor influencing the development, progression, and prognosis of endometrial cancer. This article examines the impact of metabolic syndrome on the clinical course and outcomes of endometrial cancer, focusing on underlying biochemical mechanisms and current therapeutic approaches. Evidence suggests that metabolic syndrome contributes to tumor progression through hormonal imbalance, chronic inflammation, and altered metabolic signaling pathways. Understanding these interactions is essential for improving prognosis and developing individualized treatment strategies for patients with endometrial cancer.

Maqola ma’lumotlari
MualliflarAkbarova, Maftuna
JurnalЖанубий оролбўйи тиббиёт журнали
Nashr sanasi2026-02-07
Jild1
Son4
Betlar703-707
TilIngliz

Kalit so‘zlar

Endometrial cancer, metabolic syndrome, insulin resistance, obesity, prognosis

Ilmiy soha

Жанубий оролбўйи тиббиёт журнали jurnalidan boshqa maqolalar

Жанубий оролбўйи тиббиёт журнали — barcha maqolalar